Capricor Therap (CAPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -74,873 | -50,302 | -24,392 | -40,467 | -33,351 |
| Depreciation Amortization | 1,387 | 892 | 406 | 1,425 | 1,050 |
| Accounts receivable | 10,309 | 10,309 | 10,309 | 4 | 9,962 |
| Other Working Capital | 13,357 | 13,318 | 11,679 | -10,785 | -337 |
| Other Operating Activity | 3,576 | -772 | -4,436 | 9,827 | -2,524 |
| Operating Cash Flow | $-46,245 | $-26,556 | $-6,434 | $-39,996 | $-25,199 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,599 | -2,590 | -1,140 | -1,539 | -804 |
| Purchase Of Investment | -136,393 | -78,178 | -18,182 | -208,441 | -69,077 |
| Sale Of Investment | 197,383 | 119,208 | 43,213 | 93,796 | 77,079 |
| Investing Cash Flow | $54,391 | $38,440 | $23,891 | $-116,184 | $7,198 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 77 | 70 | 50 | 152,772 | 71,684 |
| Financing Cash Flow | $77 | $70 | $50 | $152,772 | $71,684 |
| Beginning Cash Position | 11,287 | 11,287 | 11,287 | 14,695 | 14,695 |
| End Cash Position | 19,510 | 23,241 | 28,795 | 11,287 | 68,377 |
| Net Cash Flow | $8,223 | $11,954 | $17,508 | $-3,408 | $53,683 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,245 | -26,556 | -6,434 | -39,996 | -25,199 |
| Capital Expenditure | -6,599 | -2,590 | -1,140 | -1,539 | -804 |
| Free Cash Flow | -52,844 | -29,146 | -7,574 | -41,535 | -26,004 |